已发表论文

火龙罐联合无创通气对伴低氧血症 COPD 患者肺功能和炎症反应的协同作用:一项单中心回顾性研究

 

Authors Ye W , Yu Z, Yang Y, Lu H, Mo D

Received 26 June 2025

Accepted for publication 2 January 2026

Published 13 January 2026 Volume 2026:19 549734

DOI https://doi.org/10.2147/JIR.S549734

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Yuhan Xing

Weijie Ye,1,* Zhiying Yu,2,* Yubin Yang,3 Haonan Lu,1 Dieyi Mo4 

1Department of Respiratory, Panyu Maternal and Child Care Service Center of Guangzhou (He Xian Memorial Affiliated Hospital), Guangzhou, People’s Republic of China; 2Department of Traditional Chinese Medical Science, Panyu Maternal and Child Care Service Center of Guangzhou (He Xian Memorial Affiliated Hospital), Guangzhou, People’s Republic of China; 3Department of Ophthalmology, Panyu Maternal and Child Care Service Center of Guangzhou (He Xian Memorial Affiliated Hospital), Guangzhou, People’s Republic of China; 4Department of Anesthesiology, Panyu Maternal and Child Care Service Center of Guangzhou (He Xian Memorial Affiliated Hospital), Guangzhou, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Dieyi Mo, Department of Anesthesiology, Panyu Maternal and Child Care Service Center of Guangzhou (He Xian Memorial Affiliated Hospital), Guangzhou, People’s Republic of China, Email 15243936@qq.com

Purpose: Chronic obstructive pulmonary disease (COPD) with hypoxemia is associated with high morbidity and mortality. Fire dragon jar moxibustion, a Traditional Chinese Medicine(TCM) therapy, may complement non-invasive ventilation (NIV).
Methods: In this single-center retrospective study, 100 hospitalized COPD patients with hypoxemia (PaO2 < 60 mmHg) received NIV alone (control, n=50) or NIV plus moxibustion (treatment, n=50). Outcomes included FEV1, PaO2, inflammatory markers (PCT, CRP), dyspnea (mMRC), exacerbation frequency, TCM tongue-pulse scores, 30-day readmission, oxygen dependency, and glucocorticoid use. Primary endpoints were FEV1 improvement and PaO2 change at 12 weeks.
Results: At 12 weeks, the treatment group showed greater improvement in FEV1 (17.4% vs 8.7%, P < 0.01) and PaO2 (+6.4 mmHg vs − 1.2 mmHg, P < 0.001). PCT and CRP decreased more markedly in the treatment group (P < 0.05). Dyspnea (mMRC) decreased by 1.3 points vs 0.4 points in controls, and annual exacerbation frequency reduced by 1.8 vs 0.6 (P < 0.001). TCM tongue and pulse scores improved, with a trend from phlegm-dampness to lung qi deficiency (P < 0.05). 30-day readmission (8% vs 12%), oxygen therapy dependency (22% vs 30%), and glucocorticoid dosage (850 mg vs 1200 mg) were lower in the treatment group (P < 0.05). No serious adverse events attributable to the procedure were observed.
Conclusion: Combining fire dragon jar moxibustion with NIV significantly improves lung function, oxygenation, dyspnea, inflammatory markers, and TCM syndrome in COPD patients with hypoxemia, with a favorable safety profile.

Keywords: TCM, external therapy, dyspnea, acute exacerbation, oxygenation, safety